The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

Promoter Stake Sell 1pctPledge Above 50pctPledge ReleasedOwnership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.5%Reaction day

₹443.30

prior close

₹443.80

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%+1.0% vs market

Healthcare Service Provider peers, median of 21sector+0.5%+1.0% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.6

15m

-0.2

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.5+0.5+1.0+0.5+1.0

Next day

+1.6+0.3+1.3-0.3+1.9

+3.6-0.1+3.7-1.4+5.0

+3.4+1.0+2.4-1.0+4.4

+1.6+0.2+1.4+0.7+1.0

-0.2-1.5+1.3-1.0+0.7

+1.8-1.5+3.2-0.8+2.6

15d

+15.0-1.7+16.7-1.2+16.2

+9.5-3.1+12.6-2.1+11.6

+2.6-6.6+9.2-8.2+10.8

-5.1-12.3+7.1-16.7+11.6

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Docon Technologies Pvt Ltd, a promoter and holding company of Thyrocare, sold 53,32,860 equity shares (about 10.05% of paid-up capital) on October 24, 2025 through open-market trades. Promoter holding fell from 70.98% to 60.93%, but Docon continues to be classified as a Promoter & Holding Company. An interesting detail: before the sale, 60.93% of Docon's stake (3,23,23,232 shares) was shown as encumbered/pledged; after the sale, encumbrance dropped to zero, indicating a large release of pledged shares. Docon is itself a wholly owned subsidiary of API Holdings Ltd.

Likely market impact

A 10% promoter stake sale of this size is large enough to pressure the stock in the short term, but control remains comfortable at ~61% and the promoter tag is intact. The full release of pledged shares is a positive sign, removing a major overhang and leverage risk for the promoter group.